Invention Grant
US09278145B2 Aqueous methacetin solutions labelled with 13C having propylene glycol as a solubilizer
有权
用13C标记的含有丙二醇作为增溶剂的美沙西丁水溶液
- Patent Title: Aqueous methacetin solutions labelled with 13C having propylene glycol as a solubilizer
- Patent Title (中): 用13C标记的含有丙二醇作为增溶剂的美沙西丁水溶液
-
Application No.: US14553927Application Date: 2014-11-25
-
Publication No.: US09278145B2Publication Date: 2016-03-08
- Inventor: Martin Stockmann , Björn Riecke
- Applicant: FREIE UNIVERSITÄT BERLIN , CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN
- Applicant Address: DE Berlin DE Berlin
- Assignee: FREIE UNIVERSITÄT BERLIN,CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN
- Current Assignee: FREIE UNIVERSITÄT BERLIN,CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN
- Current Assignee Address: DE Berlin DE Berlin
- Agency: Maschoff Brennan
- Priority: DE102005028836 20050625
- Main IPC: A61K49/10
- IPC: A61K49/10 ; A61B5/00 ; A61B5/097 ; A61K49/00 ; A61K51/04 ; A61M16/06 ; C12Q1/26 ; A61B5/083 ; G01N33/497

Abstract:
An analysis method determines a functional parameter of an organ by measuring 13CO2 content in exhaled air of an individual to which a substrate has been administered. The reaction of the substrate in the body of the individual enriches the exhaled air with 13CO2. The maximum reaction rate of the substrate in the body is determined via a change of the measured 13CO2 content in the exhaled air using zero-order enzyme kinetics. An aqueous methacetin solution having a pH greater than 7.0 is used in the analysis method. A face mask separates the exhaled air from inhaled air. The face mask is configured such that inhaled and exhaled air flows essentially completely through the face mask. Exhalation and inhalation valves in the face mask allow a flow of inhaled and exhaled air through the face mask. A diagnostic method is used to determine the functional parameters of the organ.
Public/Granted literature
- US20150079619A1 AQUEOUS METHACETIN SOLUTIONS LABELLED WITH 13C HAVING PROPYLENE GLYCOL AS A SOLUBILIZER Public/Granted day:2015-03-19
Information query